查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1298856

連續血糖監測系統市場：2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測

Continuous Glucose Monitoring Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

2022年，全球連續血糖監測系統的市場規模達到61億美元。展望未來，IMARC Group預計到2028年市場規模將達到86億美元，在2023-2028年期間表現出5.7%的成長率（CAGR）。

連續葡萄糖監測系統（CGMS）是技術先進的設備，可以自動追踪血糖水準。它們由一個發射器整合的感測器組成，通過經皮或皮下途徑發揮作用，連續測量間質中的葡萄糖濃度。然後發射器將資訊發送到一個可以夾在衣服上的無線監測器。連續葡萄糖監測系統有助於提供糖尿病的完整概況，提醒血糖水準的高低，檢測模式，並增加病人對身體活動、藥物選擇、食物份量和壓力的了解。與傳統的葡萄糖監測設備相比，CGMS是無刺的，因為它們可以放在皮膚上，從而有助於以快速和無痛的方式提供即時資訊。

連續葡萄糖監測系統的市場趨勢：

全球範圍內的老年人口不斷增加，他們更容易患上糖尿病，這給市場帶來了積極的前景。 CGMS通常用於測量體內的葡萄糖和胰島素水準，如果下降或上升到一個危險的水準，就會進一步發出警報。與此相應，廣泛利用產品來即時識別低血糖和高血糖的情況，有利於市場成長。此外，幫助檢測糖尿病患者的糖化血紅蛋白（Hb1ac）的CGMS的重大改進和新技術進步正在為市場成長提供相當大的推動力。此外，人工胰腺設備系統與CGMS技術的整合，以泵送胰島素和施用最佳劑量來管理病人的血糖水準，對市場成長產生了積極的影響。除此之外，非侵入性CGMS設備的引入作為一種方便的選擇，廣泛的研究和開發（R&D）活動以及對較少或微創的診斷工具的需求增加，預計將進一步推動市場的成長。

目錄

第一章：前言

第二章：範圍和方法

  • 研究的目標
  • 利益相關者
  • 數據來源
    • 主要來源
    • 二級來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第三章：執行摘要

第四章：簡介

  • 概述
  • 主要行業趨勢

第五章：全球連續血糖監測系統市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第六章：按組件分類的市場

  • 感測器
    • 市場趨勢
    • 市場預測
  • 發射器和接收器
    • 市場趨勢
    • 市場預測
  • 整合式胰島素泵
    • 市場趨勢
    • 市場預測

第7章：按人口統計學分類的市場

  • 兒童人口（≤14歲）
    • 市場趨勢
    • 市場預測
  • 成人人口（大於14歲）
    • 市場趨勢
    • 市場預測

第8章：按終端用戶分類的市場

  • 診所和診斷中心
    • 市場趨勢
    • 市場預測
  • ICU
    • 市場趨勢
    • 市場預測
  • 家庭保健
    • 市場趨勢
    • 市場預測

第九章：按地區分類的市場

  • 北美洲
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場預測
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場預測
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場預測
    • 韓國
      • 市場趨勢
      • 市場預測
    • 澳大利亞
      • 市場趨勢
      • 市場預測
    • 印尼
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場預測
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 義大利
      • 市場趨勢
      • 市場預測
    • 西班牙
      • 市場趨勢
      • 市場預測
    • 俄羅斯
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場預測
    • 墨西哥
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家分類的市場
    • 市場預測

第十章：SWOT分析

  • 概述
  • 優勢
  • 劣勢
  • 機會
  • 威脅

第十一章：價值鏈分析

第十二章：波特五力分析

  • 概述
  • 買方的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第十三章：價格分析

第十四章：競爭格局

  • 市場結構
  • 主要參與者
  • 主要參與者的概況
    • A. Menarini Diagnostics Srl
    • Abbott Laboratories
    • DexCom Inc.
    • F. Hoffmann-La Roche AG
    • Glysens Incorporated
    • LifeScan Inc. (Johnson & Johnson)
    • Medtronic PLC
    • Medtrum Technologies Inc.
    • Nemaura Medical Inc.
    • Novo Nordisk A/S
    • Senseonics Holdings Inc.
    • Waveform Technologies Inc.
Product Code: SR112023A5377

The global continuous glucose monitoring systems market size reached US$ 6.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.6 Billion by 2028, exhibiting a growth rate (CAGR) of 5.7% during 2023-2028.

Continuous glucose monitoring systems (CGMS) are technologically advanced devices that automatically track blood glucose levels. They consist of a transmitter-integrated sensor that functions through a transcutaneous or subcutaneous route to continuously measure the glucose concentration in interstitial fluid. The transmitter then sends the information to a wireless monitor that can be clipped to clothes. Continuous glucose monitoring systems assist in providing a complete profile of diabetes, alerting highs and lows of blood sugar levels, detecting patterns, and increasing patient insights regarding physical activity, medication choices, food portions and stress. As compared to conventional glucose monitoring devices, CGMS are prick-free as they can be placed over the skin, thus aiding in providing real-time information in a quick and painless fashion.

Continuous Glucose Monitoring Systems Market Trends:

The rising geriatric population across the globe that are more susceptible to developing diabetes is creating a positive outlook for the market. CGMS is commonly used for measuring glucose and insulin level in the body, which further sounds an alarm if it drops or rises to a dangerous level. In line with this, the widespread product utilization to identify hypoglycemia and hyperglycemic situations in real-time is favoring the market growth. Moreover, significant improvements and new technological advancements in CGMS that aid in detecting glycated hemoglobin (Hb1ac) in patients with diabetes are providing a considerable boost to the market growth. Additionally, the integration of artificial pancreas device systems with CGMS technology to pump insulin and administer optimum dosage to manage the blood sugar levels of patients is positively impacting the market growth. Apart from this, the introduction of non-invasive CGMS devices as a convenient alternative, extensive research and development (R&D) activities and the increasing demand for less or minimally invasive diagnostic tools are anticipated to drive the market further toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global continuous glucose monitoring systems market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on component, demographics and end user.

Breakup by Component:

Sensors

Transmitters and Receivers

Integrated Insulin Pumps

Breakup by Demographics:

Child Population (≤14 years)

Adult Population (>14 years)

Breakup by End User:

Clinics and Diagnostics Centers

ICUs

Home Healthcare

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being A. Menarini Diagnostics S.r.l., Abbott Laboratories, DexCom Inc., F. Hoffmann-La Roche AG, Glysens Incorporated, LifeScan Inc. (Johnson & Johnson), Medtronic PLC, Medtrum Technologies Inc., Nemaura Medical Inc., Novo Nordisk A/S, Senseonics Holdings Inc. and Waveform Technologies Inc.

Key Questions Answered in This Report1. What was the size of the global continuous glucose monitoring systems market in 2022?

2. What is the expected growth rate of the global continuous glucose monitoring systems market during 2023-2028?

3. What has been the impact of COVID-19 on the global continuous glucose monitoring systems market?

4. What are the key factors driving the global continuous glucose monitoring systems market?

5. What is the breakup of the global continuous glucose monitoring systems market based on the component?

6. What is the breakup of the global continuous glucose monitoring systems market based on the demographics?

7. What is the breakup of the global continuous glucose monitoring systems market based on end user?

8. What are the key regions in the global continuous glucose monitoring systems market?

9. Who are the key players/companies in the global continuous glucose monitoring systems market?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Continuous Glucose Monitoring Systems Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Component

  • 6.1  Sensors 
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Transmitters and Receivers 
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Integrated Insulin Pumps
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7   Market Breakup by Demographics

  • 7.1  Child Population (≤14 years)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Adult Population (>14 years)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8   Market Breakup by End User

  • 8.1  Clinics and Diagnostics Centers
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  ICUs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3  Home Healthcare
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9   Market Breakup by Region

  • 9.1  North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2  Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3  Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4  Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5  Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10  SWOT Analysis

  • 10.1  Overview
  • 10.2  Strengths
  • 10.3  Weaknesses
  • 10.4  Opportunities
  • 10.5  Threats

11  Value Chain Analysis

12  Porters Five Forces Analysis

  • 12.1  Overview
  • 12.2  Bargaining Power of Buyers
  • 12.3  Bargaining Power of Suppliers
  • 12.4  Degree of Competition
  • 12.5  Threat of New Entrants
  • 12.6  Threat of Substitutes

13  Price Analysis

14  Competitive Landscape

  • 14.1  Market Structure
  • 14.2  Key Players
  • 14.3  Profiles of Key Players
    • 14.3.1  A. Menarini Diagnostics S.r.l.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2  Abbott Laboratories
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3  DexCom Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4  F. Hoffmann-La Roche AG
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5  Glysens Incorporated
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6  LifeScan Inc. (Johnson & Johnson)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7  Medtronic PLC
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8  Medtrum Technologies Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9  Nemaura Medical Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10  Novo Nordisk A/S
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11  Senseonics Holdings Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12  Waveform Technologies Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Continuous Glucose Monitoring Systems Market: Major Drivers and Challenges
  • Figure 2: Global: Continuous Glucose Monitoring Systems Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Continuous Glucose Monitoring Systems Market: Breakup by Component (in %), 2022
  • Figure 5: Global: Continuous Glucose Monitoring Systems Market: Breakup by Demographics (in %), 2022
  • Figure 6: Global: Continuous Glucose Monitoring Systems Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Continuous Glucose Monitoring Systems Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Continuous Glucose Monitoring Systems (Sensors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Continuous Glucose Monitoring Systems (Sensors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Continuous Glucose Monitoring Systems (Transmitters and Receivers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Continuous Glucose Monitoring Systems (Transmitters and Receivers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Continuous Glucose Monitoring Systems (Integrated Insulin Pumps) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Continuous Glucose Monitoring Systems (Integrated Insulin Pumps) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Continuous Glucose Monitoring Systems (Child Population (≤14 years)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Continuous Glucose Monitoring Systems (Child Population (≤14 years)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Continuous Glucose Monitoring Systems (Adult Population (>14 years)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Continuous Glucose Monitoring Systems (Adult Population (>14 years)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Continuous Glucose Monitoring Systems (Clinics and Diagnostics Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Continuous Glucose Monitoring Systems (Clinics and Diagnostics Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Continuous Glucose Monitoring Systems (ICUs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Continuous Glucose Monitoring Systems (ICUs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Continuous Glucose Monitoring Systems (Home Healthcare) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Continuous Glucose Monitoring Systems (Home Healthcare) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: North America: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: North America: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: United States: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: United States: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Canada: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Canada: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Asia-Pacific: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Asia-Pacific: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: China: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: China: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Japan: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Japan: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: India: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: India: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: South Korea: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: South Korea: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Australia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Australia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Indonesia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Indonesia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Europe: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Europe: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Germany: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Germany: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: France: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: France: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: United Kingdom: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: United Kingdom: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Italy: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Italy: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Spain: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Spain: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Russia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Russia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Latin America: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Latin America: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Brazil: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Brazil: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Mexico: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Mexico: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Middle East and Africa: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Middle East and Africa: Continuous Glucose Monitoring Systems Market: Breakup by Country (in %), 2022
  • Figure 72: Middle East and Africa: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Global: Continuous Glucose Monitoring Systems Industry: SWOT Analysis
  • Figure 74: Global: Continuous Glucose Monitoring Systems Industry: Value Chain Analysis
  • Figure 75: Global: Continuous Glucose Monitoring Systems Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Continuous Glucose Monitoring Systems Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Component (in Million US$), 2023-2028
  • Table 3: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Demographics (in Million US$), 2023-2028
  • Table 4: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Continuous Glucose Monitoring Systems Market: Competitive Structure
  • Table 7: Global: Continuous Glucose Monitoring Systems Market: Key Players